NDAORALSUSPENSIONPriority Review
Approved
Jun 2021
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
10
Clinical Trials (5)
Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
Started May 2023
44 enrolled
Smallpox
Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
Started Dec 2018
0Adenovirus
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
Started Sep 2015
5 enrolled
Cytomegalovirus Disease
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
Started Sep 2015
6 enrolled
Cytomegalovirus DiseaseKidney Transplant Infection
An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola
Started Oct 2014
0Ebola Virus Disease
Loss of Exclusivity
LOE Date
Aug 31, 2031
66 months away
Patent Expiry
Aug 31, 2031
Exclusivity Expiry
Jun 4, 2028
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9303051 | Aug 31, 2031 | SubstanceProduct | U-3165 |